R&D-driven medical progress, health care costs, and the future of human longevity
Saved in:
Böhm, S., et al., R&D-driven medical progress, health care costs, and the future of human longevity. The Journal of the Economics of Ageing, vol. 18, 2021, p. 1-18.
Ref.
568494
Location:
SIIS Archivo (R.1961)
Palabras clave:
Medicina, Nuevas tecnologías, Esperanza de vida, Atención sanitaria, Acceso, Coste, Morbilidad, Evolución
Medicina, Nuevas tecnologías, Esperanza de vida, Atención sanitaria, Acceso, Coste, Morbilidad, Evolución
Similar Items: R&D-driven medical progress, health care costs, and the future of human longevity
- THE IRS2 GLY 1057 ASP VARIANT IS ASSOCIATED WITH HUMAN LONGEVITY
- Modeling the impact of COVID-19 pandemic-driven increases in alcohol consumption on health outcomes and hospitalization costs in the United States
- A HUMAN DEVELOPMENT INTERVENTION IN THE PHILIPPINES: EFFECT ON CHILD MORBIDITY
- Global Alliance International Longevity Centre. Designing the future of ageing
- Facial appearance reflects human familial longevity and cardiovascular disease fisk in healthy individuals
- NUTRITION AND LONGEVITY